123 related articles for article (PubMed ID: 19918833)
1. Synthesis, enzymatic evaluation, and docking studies of fluorogenic caspase 8 tetrapeptide substrates.
Reszka P; Schulz R; Methling K; Lalk M; Bednarski PJ
ChemMedChem; 2010 Jan; 5(1):103-17. PubMed ID: 19918833
[TBL] [Abstract][Full Text] [Related]
2. Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex.
Blanchard H; Donepudi M; Tschopp M; Kodandapani L; Wu JC; Grütter MG
J Mol Biol; 2000 Sep; 302(1):9-16. PubMed ID: 10964557
[TBL] [Abstract][Full Text] [Related]
3. Purification and catalytic properties of human caspase family members.
Garcia-Calvo M; Peterson EP; Rasper DM; Vaillancourt JP; Zamboni R; Nicholson DW; Thornberry NA
Cell Death Differ; 1999 Apr; 6(4):362-9. PubMed ID: 10381624
[TBL] [Abstract][Full Text] [Related]
4. Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity.
Pereira NA; Song Z
Biochem Biophys Res Commun; 2008 Dec; 377(3):873-7. PubMed ID: 18976637
[TBL] [Abstract][Full Text] [Related]
5. Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling.
Fang B; Fu G; Agniswamy J; Harrison RW; Weber IT
Apoptosis; 2009 May; 14(5):741-52. PubMed ID: 19283487
[TBL] [Abstract][Full Text] [Related]
6. N-Ac-DEVD-N'-(Polyfluorobenzoyl)-R110: novel cell-permeable fluorogenic caspase substrates for the detection of caspase activity and apoptosis.
Zhang HZ; Kasibhatla S; Guastella J; Tseng B; Drewe J; Cai SX
Bioconjug Chem; 2003; 14(2):458-63. PubMed ID: 12643757
[TBL] [Abstract][Full Text] [Related]
7. Structural and kinetic analysis of caspase-3 reveals role for s5 binding site in substrate recognition.
Fang B; Boross PI; Tozser J; Weber IT
J Mol Biol; 2006 Jul; 360(3):654-66. PubMed ID: 16781734
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional definition of the specificity of a novel caspase-3 inhibitor, Ac-DNLD-CHO.
Yoshimori A; Sakai J; Sunaga S; Kobayashi T; Takahashi S; Okita N; Takasawa R; Tanuma S
BMC Pharmacol; 2007 Jun; 7():8. PubMed ID: 17594508
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10.
Ekici OD; Li ZZ; Campbell AJ; James KE; Asgian JL; Mikolajczyk J; Salvesen GS; Ganesan R; Jelakovic S; Grütter MG; Powers JC
J Med Chem; 2006 Sep; 49(19):5728-49. PubMed ID: 16970398
[TBL] [Abstract][Full Text] [Related]
10. Exploiting differences in caspase-2 and -3 S₂ subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors.
Maillard MC; Brookfield FA; Courtney SM; Eustache FM; Gemkow MJ; Handel RK; Johnson LC; Johnson PD; Kerry MA; Krieger F; Meniconi M; Muñoz-Sanjuán I; Palfrey JJ; Park H; Schaertl S; Taylor MG; Weddell D; Dominguez C
Bioorg Med Chem; 2011 Oct; 19(19):5833-51. PubMed ID: 21903398
[TBL] [Abstract][Full Text] [Related]
11. Conformational similarity in the activation of caspase-3 and -7 revealed by the unliganded and inhibited structures of caspase-7.
Agniswamy J; Fang B; Weber IT
Apoptosis; 2009 Oct; 14(10):1135-44. PubMed ID: 19655253
[TBL] [Abstract][Full Text] [Related]
12. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
[TBL] [Abstract][Full Text] [Related]
13. N-DEVD-N'-morpholinecarbonyl-rhodamine 110: novel caspase-3 fluorogenic substrates for cell-based apoptosis assay.
Wang ZQ; Liao J; Diwu Z
Bioorg Med Chem Lett; 2005 May; 15(9):2335-8. PubMed ID: 15837320
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and discovery of novel non-peptide inhibitor of Caspase-3 using ligand based and structure based virtual screening approach.
Lakshmi PJ; Kumar BV; Nayana RS; Mohan MS; Bolligarla R; Das SK; Bhanu MU; Kondapi AK; Ravikumar M
Bioorg Med Chem; 2009 Aug; 17(16):6040-7. PubMed ID: 19631549
[TBL] [Abstract][Full Text] [Related]
15. Design of fluorogenic peptide substrates for human cytomegalovirus protease based on structure-activity relationship studies.
Bonneau PR; Plouffe C; Pelletier A; Wernic D; Poupart MA
Anal Biochem; 1998 Jan; 255(1):59-65. PubMed ID: 9448842
[TBL] [Abstract][Full Text] [Related]
16. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
17. Structure-based discovery of a novel non-peptidic small molecular inhibitor of caspase-3.
Sakai J; Yoshimori A; Nose Y; Mizoroki A; Okita N; Takasawa R; Tanuma S
Bioorg Med Chem; 2008 May; 16(9):4854-9. PubMed ID: 18387304
[TBL] [Abstract][Full Text] [Related]
18. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
19. First examples of peptidomimetic inhibitors of interleukin-1 beta converting enzyme.
Dolle RE; Prouty CP; Prasad CV; Cook E; Saha A; Ross TM; Salvino JM; Helaszek CT; Ator MA
J Med Chem; 1996 Jun; 39(13):2438-40. PubMed ID: 8691439
[No Abstract] [Full Text] [Related]
20. Function of caspases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors.
Gregoli PA; Bondurant MC
J Cell Physiol; 1999 Feb; 178(2):133-43. PubMed ID: 10048577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
